## Pathological Mechanism of Type 1 Diabetes **Key Point:** This patient presents with acute-onset diabetes with ketoacidosis, undetectable C-peptide, and positive autoimmune markers (anti-GAD, anti-IA2), diagnostic of Type 1 Diabetes Mellitus (T1DM). ### Pathophysiology of T1DM Type 1 Diabetes is an **autoimmune disorder** characterized by: 1. **T-cell mediated destruction** of insulin-producing β-cells in pancreatic islets 2. **Loss of insulin secretion** (evidenced by undetectable C-peptide) 3. **Acute presentation** with hyperglycemia, ketosis, and metabolic acidosis ### Autoimmune Markers in T1DM | Marker | Frequency | Significance | |--------|-----------|---------------| | Anti-GAD65 | 70–80% | Glutamic acid decarboxylase; early marker | | Anti-IA2 | 50–60% | Islet antigen-2; indicates ongoing autoimmunity | | Anti-ZnT8 | 50–60% | Zinc transporter; β-cell specific | | Anti-insulin | 40–50% | Present at diagnosis, especially in children | **Clinical Pearl:** The presence of **two or more autoantibodies** (this patient has anti-GAD and anti-IA2) confirms autoimmune β-cell destruction and distinguishes T1DM from other forms of diabetes. ### Why Ketoacidosis Occurs Without insulin: - Glucose cannot enter cells → hyperglycemia - Lipolysis increases → free fatty acids to liver - Fatty acids → ketone bodies (acetoacetate, β-hydroxybutyrate) - Ketones accumulate → metabolic acidosis (pH 7.28, HCO₃⁻ 12) **High-Yield:** Undetectable C-peptide + positive autoantibodies + acute ketoacidosis = **Type 1 Diabetes with autoimmune β-cell destruction**. This is the hallmark pathological finding. [cite:Robbins 10e Ch 20]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.